|
Antimicrobial agent
|
MIC50
|
MIC90
|
Range
|
% susceptible / resistanta
|
|---|
|
Ceftazidime
|
2
|
>16
|
≤1 – >16
|
71.7 / 24.0
|
|
Cefepime
|
4
|
16
|
0.5 – >16
|
77.9 / 9.9
|
|
Piperacillin/tazobactamb
|
8
|
>64
|
≤0.5 – >64
|
68.8 / 15.5
|
|
Imipenem
|
2
|
>8
|
≤0.12 – >8
|
74.9 / 17.8
|
|
Meropenem
|
0.5
|
>8
|
≤0.12 – >8
|
76.4 / 12.8
|
|
Ciprofloxacin
|
0.25
|
>4
|
≤0.03 – >4
|
75.2 / 20.0
|
|
Levofloxacin
|
≤0.5
|
>4
|
≤0.5 – >4
|
74.2 / 24.0
|
|
Gentamicin
|
≤2
|
>8
|
≤2 – >8
|
64.1 / 31.9
|
|
Amikacin
|
4
|
>32
|
≤4 – >32
|
70.3 / 23.7
|
|
PolymyxinB
|
1
|
1
|
≤0.5 – 2
|
100.0 / 0.0
|
|
Colistin
|
1
|
2
|
≤0.5 – 2
|
100.0 / 0.0
|
- a Criteria as published by the CLSI [16].
- b Criteria published by the CLSI [15].
